{
    "title": "To amend title XVIII of the Social Security Act to improve the diagnosis and treatment of lymphedema under the Medicare program and to reduce costs under such program related to the treatment of lymphedema.",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Lymphedema Diagnosis and Treatment \nCost-Saving Act of 2011''.\n\nSEC. 2. COVERAGE OF LYMPHEDEMA DIAGNOSIS AND TREATMENT SERVICES UNDER \n              MEDICARE.\n\n    (a) Coverage of Services.--Section 1861 of the Social Security Act \n(42 U.S.C. 1395x) is amended--\n            (1) in subsection (s)(2)--\n                    (A) in subparagraph (EE), by striking ``and'' at \n                the end;\n                    (B) in subparagraph (FF), by adding ``and'' at the \n                end; and\n                    (C) by adding at the end the following new \n                subparagraph:\n                    ``(GG)(i) lymphedema diagnosis services (as defined \n                in subsection (iii)(1)) and lymphedema treatment \n                services (as described in subsection (iii)(2)); and\n                    ``(ii) lymphedema compression treatment items (as \n                defined in subsection (jjj)).''; and\n            (2) by adding at the end the following new subsections:\n    ``(iii) Lymphedema Diagnosis and Treatment Services.--(1) \nLymphedema Diagnosis Services.--The term `lymphedema diagnosis \nservices' means, with respect to an individual, the differential \ndiagnosis of the source of the individual's edema and the \nidentification of the specific etiology and functional lymphatic \ndeficiency, in which such diagnosis--\n            ``(A) is provided by a provider, as defined in paragraph \n        (3), for the purpose of developing a lymphedema treatment plan; \n        and\n            ``(B) may utilize any diagnostic tools the provider \n        determines to be reasonable and necessary.\n    ``(2) Lymphedema Treatment Services.--The term `lymphedema \ntreatment services' means, with respect to an individual, services for \nthe treatment of lymphedema (regardless of cause)--\n            ``(A) that are--\n                    ``(i) provided in an inpatient or outpatient \n                setting;\n                    ``(ii) provided by a provider, as defined in \n                paragraph (3), within the established scope of practice \n                of such provider; and\n                    ``(iii) medically necessary, in accordance with the \n                current standard of lymphedema treatment, including \n                complete decongestive therapy, which is a multi-modal \n                therapy comprising of manual lymph drainage, \n                compression therapy utilizing multilayer bandage \n                systems, compression garments and devices, exercise, \n                skin care, patient education, and any other lymphedema \n                treatment modalities determined by the Secretary to be \n                safe and effective; and\n            ``(B) which shall--\n                    ``(i) include as medically necessary with respect \n                to the individual--\n                            ``(I) an initial evaluation and course of \n                        clinical treatment, including initial baseline \n                        measurements and subsequent measurements to \n                        assess treatment efficacy and progress;\n                            ``(II) follow-up courses of clinical \n                        treatment;\n                            ``(III) in the case that such individual \n                        has cancer, clinical measurements, including \n                        initial pre-operative baseline measurements and \n                        periodic subsequent measurements to diagnose \n                        the presence of lymphedema; and\n                            ``(IV) any other treatment modality \n                        approved by the Secretary; and\n                    ``(ii) be provided in accordance with such \n                schedule, duration, and number of treatments as \n                determined medically necessary.\n    ``(3) Provider Defined.--For purposes of this subsection and \nsubsection (jjj), the term `provider' means any licensed medical or \nhealth care provider whose State licensing board recognizes lymphedema \ndiagnosis, lymphedema treatment, or both to fall within the scope of \npractice of such medical or health care provider.\n    ``(jjj) Lymphedema Compression Treatment Items.--The term \n`lymphedema compression treatment items' means, with respect to an \nindividual, compression garments, devices, bandaging systems, \ncomponents, and supplies that are primarily and customarily used in the \nmedical treatment of lymphedema of the arms, hands, legs, feet, torso, \nface and neck, breast and chest, abdomen, and genitalia, as prescribed \nby a provider, as defined in subsection (iii)(3). Such term includes--\n            ``(1) multilayer compression bandaging systems, including \n        short-stretch and medium-stretch compression bandages; cotton, \n        synthetic, or foam padding; gauze or elastic finger and toe \n        bandages; foam pads; directional flow padding; and tubular \n        bandages;\n            ``(2) custom or standard fit gradient compression garments;\n            ``(3) non-elastic and low-elastic compression garments, \n        manually adjustable or fitted padded directional flow garments \n        (with or without elastic or non-elastic compression jackets) \n        and compression wraps and directional flow pads;\n            ``(4) aids and ancillary equipment consisting of donning \n        aids, bandage rollers, shoes to fit over compression items, and \n        other specialized items used with the items described in \n        paragraphs (1) through (3);\n            ``(5) pneumatic appliances connected to and used in \n        conjunction with pneumatic sequential compression controllers;\n            ``(6) any other compression garments, bandaging systems, \n        devices, and aids determined by the Secretary to be effective \n        in the prevention or treatment of lymphedema; and\n            ``(7) replacements of any items under this subsection in \n        accordance with section 1834(p)(3).''.\n    (b) Payment.--\n            (1) Lymphedema compression treatment items.--\n                    (A) In general.--Section 1833(a) of such Act (42 \n                U.S.C. 1395l(a)) is amended--\n                            (i) in paragraph (8), by striking at the \n                        end ``and'';\n                            (ii) in paragraph (9), by striking at the \n                        end the period and inserting a semi-colon; and\n                            (iii) by adding at the end the following \n                        new paragraph:\n            ``(10) in the case of lymphedema compression treatment \n        items described in section 1861(jjj), the amount determined \n        under section 1834(p); and''.\n                    (B) Payment determined.--Section 1834 of such Act \n                (42 U.S.C. 1395m) is amended by adding at the end the \n                following new subsection:\n    ``(p) Payment for Lymphedema Compression Treatment Items.--\n            ``(1) General rule for payment.--\n                    ``(A) In general.--With respect to a lymphedema \n                compression treatment item as defined in section \n                1861(jjj)) for which payment is determined under this \n                subsection, subject to subparagraph (D), payment shall \n                be made in an amount equal to 80 percent of the payment \n                basis described in subparagraph (B).\n                    ``(B) Payment basis.--The payment basis described \n                in this subparagraph, with respect to a lymphedema \n                compression treatment item described in section \n                1861(jjj), is the actual charge for the item.\n                    ``(C) Exclusive payment rule for home health \n                agencies.--Notwithstanding any other provision of this \n                title, this subsection shall constitute the exclusive \n                provision of this title for payment for lymphedema \n                compression treatment items described in section \n                1861(jjj) under this part or under part A to a home \n                health agency or for such items that are furnished as \n                an incident to a physician's professional service.\n            ``(2) Allowable quantities.--In the case it is determined \n        by a provider, as defined in section 1861(iii)(3), that \n        lymphedema compression treatment items are required as part of \n        lymphedema treatment services under section 1861(iii)(2), then \n        payment may be made under this title in accordance with this \n        subsection for such items in the quantity which is customary, \n        reasonable, and medically necessary.\n            ``(3) Replacement of lymphedema compression treatment \n        items.--\n                    ``(A) In general.--Payment shall be made under this \n                subsection, with respect to an individual, for the \n                replacement of a lymphedema compression treatment item \n                if the period of the reasonable and useful lifetime of \n                the item (as described in subparagraph (B)) has expired \n                or a provider, as defined in section 1861(iii)(3), \n                determines that a replacement, or repair, of such item, \n                is medically necessary.\n                    ``(B) Reasonable and useful lifetime.--For purposes \n                of subparagraph (A), the period of the reasonable and \n                useful lifetime of a lymphedema compression treatment \n                item is as follows:\n                            ``(i) In the case of any item described in \n                        section 1861(jjj)(1), 1 year.\n                            ``(ii) In the case of any item described in \n                        section 1861(jjj)(2), 6 months.\n                            ``(iii) In the case of any item described \n                        in section 1861(jjj)(3), 2 years.\n                            ``(iv) In the case of any item described in \n                        section 1861(jjj)(4), 1 year.\n                            ``(v) In the case of any item described in \n                        section 1861(jjj)(5), 5 years.\n                            ``(vi) In the case of any item described in \n                        section 1861(jjj)(6), such period as determined \n                        by the Secretary, in consultation with \n                        appropriate health organizations, at the time \n                        the Secretary determines such item to be \n                        effective in the prevention or treatment of \n                        lymphedema.''.\n                    (C) Application of supplier requirements.--Section \n                1834(j)(5) of such Act (42 U.S.C. 1395m(j)(5)) is \n                amended--\n                            (i) in subparagraph (E), by striking at the \n                        end ``and'';\n                            (ii) in subparagraph (F), by striking at \n                        the end the period and inserting ``; and''; and\n                            (iii) by adding at the end the following \n                        new subparagraph:\n                    ``(G) lymphedema compression treatment items (as \n                defined in section 1861(jjj)).''.\n            (2) Lymphedema diagnosis and treatment services.--\n                    (A) In general.--Section 1833(a) of such Act, as \n                amended by paragraph (1)(A), is further amended by \n                adding at the end the following new paragraph:\n            ``(11)(A) in the case of lymphedema diagnosis services (as \n        defined in section 1861(iii)(1)) furnished by a provider (as \n        defined in section 1861(iii)(3)) the amount described in \n        section 1834(q); and\n            ``(B) in the case of lymphedema treatment services (as \n        defined in section 1861(iii)(2)) furnished by a provider (as \n        defined in section 1861(iii)(3)) the amount described in \n        section 1834(k).''.\n                    (B) Payment method.--Section 1834 of such Act, as \n                amended by paragraph (1)(B), is further amended by \n                adding at the end the following new subsection:\n    ``(q) Payment for Outpatient Lymphedema Diagnosis and Treatment \nServices by Physicians and Non-Physician Practitioners.--\n            ``(1) In general.--For purposes of section 1833(a)(11), the \n        amount described in this subsection, with respect to a \n        lymphedema diagnosis service or lymphedema treatment service, \n        is 80 percent of the lesser of--\n                    ``(A) the actual charge for the service; or\n                    ``(B) the applicable fee schedule amount (as \n                defined in paragraph (2)) for the service.\n            ``(2) Applicable fee schedule amount.--In this subsection, \n        the term `applicable fee schedule amount' means, with respect \n        to services furnished in a year, the amount determined under \n        the fee schedule established under section 1848 for such \n        services furnished during the year.''.\n                    (C) Conforming amendment for payments under \n                1834(k).--Section 1834(k)(1) of such Act (42 U.S.C. \n                1395m(k)(1)) is amended by striking ``or 1833(a)(9)'' \n                and inserting ``1833(a)(9), or 1833(a)(11)''.\n    (c) Effective Date.--The amendments made by this section shall \napply to items and services furnished on or after the date that is 180 \ndays from the date of the enactment of this Act."
}